Delayed luminescence for in vitro study of mitochondrial dysfunctions in neurodegenerative diseases

R. Grasso; R. Pellitteri; F. Musumeci; V. Rapicavoli; G. Sposito; A. Triglia; A. Scordino; A. Campisi

doi:10.1117/12.2526920

22 July 2019 Delayed luminescence for in vitro study of mitochondrial dysfunctions in neurodegenerative diseases

R. Grasso, R. Pellitteri, F. Musumeci, V. Rapicavoli, G. Sposito, A. Triglia, A. Scordino, A. Campisi

Proceedings Volume 11075, Novel Biophotonics Techniques and Applications V; 110750K (2019) https://doi.org/10.1117/12.2526920
Event: European Conferences on Biomedical Optics, 2019, Munich, Germany

Abstract

Spectroscopic studies of Delayed Luminescence emitted by an in vitro model for studying of the effects of amyloid-βeta (Aβ) have been performed. Aβ is a neurotoxic protein overexpressed in Alzheimer's Disease (AD), which is also related to mitochondrial dysfunction. The experiments have been carried out on primary Olfactory Ensheathing Cells (OECs) cultures. Cells have been exposed to Aβ(1-42) native full-length peptide or to Aβ(25-35), a toxic fragment of Aβ, or Aβ(35-25), a non toxic Aβ fragment, both in absence and in presence of Astaxanthin, a well-known antioxidant agent. To monitor cell viability, MTT test was used. Reactive oxygen species and reduced glutathione levels were utilized to test the oxidative intracellular status. We also assessed the expression of some glial markers (Glial Acidic Fibrillary Protein, Vimentin), of Nestin, stem cell marker, and the activation of the apoptotic pathway assessing caspase-3 cleavage. We found that, in OECs, Glial Acidic Fibrillary Protein, Vimentin expression and caspase-3 exhibited a significant enhancement in Aβ(1–42) and Aβ(25–35) exposed cells. The pre-treatment with Astaxanthin restored the levels of Vimentin and caspase-3 to control values, increasing also Nestin expression levels and reestablished the intracellular oxidative status modified by the exposure to Aβ(1–42) or Aβ(25–35) of OECs. DL intensity and kinetics changes as a function of the treatments were also measured. In particular, an increase in DL emission, with respect the untreated cells (controls), was observed in cells exposed to Aβ(25-35) fragment. This emission appeared quenched in presence of Astaxanthin.

Citation Download Citation

R. Grasso, R. Pellitteri, F. Musumeci, V. Rapicavoli, G. Sposito, A. Triglia, A. Scordino, and A. Campisi "Delayed luminescence for in vitro study of mitochondrial dysfunctions in neurodegenerative diseases", Proc. SPIE 11075, Novel Biophotonics Techniques and Applications V, 110750K (22 July 2019); https://doi.org/10.1117/12.2526920

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available

Members: $17.00

Non-members: $21.00 ADD TO CART

PROCEEDINGS
4 PAGES

DOWNLOAD PAPER SAVE TO MY LIBRARY

GET CITATION

RIGHTS & PERMISSIONS

Get copyright permission Get copyright permission on Copyright Marketplace

KEYWORDS

Luminescence

Proteins

In vitro testing

Alzheimer's disease

Oxygen

Analytical research

Glia

Show All Keywords

Keywords/Phrases

Search In:

Publication Years